Success Stories: Resident Physician in Connecticut with 120 Citations in the Field of Oncology Obtains NIW and EB-1A Petition Approvals 2 Weeks Apart

Client’s Testimonial:

“Thank you very much for your help with my EB1A I-140 approval!”

On September 2^nd, 2016 and September 15^th, 2016, we received another EB-2 NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) approval for a Resident Physician in the Field of Oncology (Approval Notice).

General Field: Oncology

Position at the Time of Case Filing: Resident Physician

Country of Origin: China

Service Center: Texas Service Center (TSC)

State of Residence at the Time of Filing: Connecticut

Approval Notice Date: September 2^nd, 2016 (NIW) and September 15^th, 2016 (EB1A)

Processing Time: 30 Days (NIW) and 101 Days (EB1A, Premium Processing Requested, RFE)

Case Summary:

North America Immigration Law Group (NAILG) is pleased to have helped a gifted resident physician from China obtain two I-140 petition approvals—EB-2 NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability). Our client opted to file two petitions to increase the likelihood of securing an approval and he was fortunate enough to receive both approval notices just 13 days apart. With an M.D. and Ph.D. in Chemistry in the bag, our client is academically qualified to carry out impactful research in the field of oncology, which made him a suitable candidate for both visa categories.

Although EB-1A and NIW are upheld by different requirements, a significant amount of information included in our client’s two petition packets overlapped. Amongst other things, here are some of the key points that were used to strengthen both petitions:

We listed our client’s professional accomplishments such as the 120 citations gathered from his work, the 23 publications to his name, and the 54 times he conducted peer reviews for scientific journals.
In order to prove to the USCIS that our client deserved to have both his petitions approved, we had to account for his research in the field of oncology. After careful review, we determined that our client’s specialized research is focused on establishing prognostic models and biomarkers for various cancers, including glioma, lymphoma, and pancreatic cancer. We convinced the USCIS that our client’s findings contribute to medical research and the healthcare sector. Specifically, his biomarker research efforts are contributing to the United States’ approach to the treatment of cancer.
Both petition packets contained the same set of six recommendation letters contributed by our client’s peers. Not only did these letter briefly discuss our client’s research, they also verified just how important his work is to the country. This is what one of our client’s recommender said: “In light of [Client’s] many accomplishments and the consistency with which he is able to produce high-impact results, I feel it is guaranteed that his work will continue to benefit the United States and the international research community, given that he is not delayed in his pursuits.”

We are extremely pleased that our diligent efforts played a significant role in the approval of both petitions. Although our client’s journey to EB-1A petition approval was marred by a Request for Evidence (RFE), our efficient and effective response to it secured him an approval. Our client is now one step closer to his green card, and we congratulate him for coming this far. We recently helped him and his dependent prepare and file their I-485 applications. Once the USCIS approves their applications, they will receive their green cards. We wish our client the best with this.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.